Hasbek, Zekiye Cumhuriyet University - School of Medicine - Department of Nuclear Medicine, Turkey , Durmuş, Kasım Cumhuriyet University - School of Medicine - Department of Otolaryngology, Turkey , Engin, Aynur Cumhuriyet University - School of Medicine - Department of Infect ious Diseases and Clinical Microbiology, Turkey , Altuntaş, Emine Elif Cumhuriyet University - School of Medicine - Department of Otolaryngology, Turkey

Development of parotitis after radioiodine therapy in a differentiated thyroid cancer patient: Case report

33513

In this article, we report a 51 years old female patient treated with radioactive iodine (RAI-131I) treatment for thyroid papillary carcinoma and developing parotitis on the 24 hour following treatment. Siaload enitis after high dose ablative therapy with 131I is a relatively common complication with a low clinical impression. Taste alteration or loss, and nausea and vomiting due to radiation sickness are the other most frequent side effects. Xerostomia is an important problem increasing morbidity of the patients. For this reason, it is important to prevent xerostamia by following serum amylase levels in symptomatic patients. By taking into account that not only bacterial and viral factors but also radiation may cause sialoadenitis, one has to rule out other parotisis possibilities by clinical and laboratory findings before claiming that salivary gland enlargement developing after radioiodine is a complication of radiation. Moreover, history of RAI treatment should be given importance in patients applying either to emergency services or to Ear Nose Throat and Infectious Diseases Department with dry mouth.

53

Radioiodine therapy , differentiated thyroid carcinoma , parotitis

Cumhuriyet Medical Journal

56